Download
Download by
Scanning QR Code
No matches yet
Please check network settings and try again Refresh
Loading
Futu Hot Stocks
    Latest News
    History record delete
      Quotes All >
      News All >
      Help All >

      • Download app

        Download app

      +
      Congratulations
      You've successfully got advanced quotes worth 5000 HKD
      Download APP >>
      Quotes
      Detailed Quotes
      Company Overview
      Company ProfileCompany Executives
      Financial Analysis
      Main CompositionKey IndicatorsFinancial Statement
      Multi-dimentional Analyses
      Company Valuation Capital Tracking Short Selling Data
      Futubull > Quotes > TCBP TC BioPharm > Key Indicators
      TCBP TC BioPharm
      0.7100.0000.00%
      Post Mkt Price
      0.691
      -0.019-2.65%
      YOY
      Do not show
      Hide blank lines
      (FY)2022/12/31(Q4)2022/12/31(Q2)2022/06/30(FY)2021/12/31
      Financial Ratios
      Efficiency Ratios TTM
      Receivable Turnover（T）
      -- 136.6605 -- 136.6605 -- 84.2664 -- --
      Fixed Assets Turnover（T）
      143.37% 1.159 -- 1.159 -- 0.6121 23.23% 0.4762
      Total Asset Rate（T）
      56.58% 0.4052 -- 0.4052 -- 0.1458 13.84% 0.2588
      ROIC
      -- -- -- -- -- -57.919% -- --
      ROE
      -- -- -- -- -- -1022.187% -- --
      ROA
      91.75% -14.648% -- -14.648% -- -76.734% -183.16% -177.576%
      Efficiency Ratios
      Profitability Ratios TTM
      Operating Margin
      15.73% -310.080% -- -310.080% -- -626.811% -14.86% -367.958%
      Net Margin
      94.73% -36.148% -- -36.148% -- -526.370% -148.74% -686.118%
      EBITDA Margin
      123.73% 1.2618% -- 1.2618% -- -0.9947% -99.90% -5.3167%
      R & D Expense Ratio
      -37.74% 193.720% -- 193.720% -- 351.110% -7.83% 311.160%
      Sales Expense Ratio
      -- 0.000% -- 0.000% -- 0.000% -- 0.000%
      Administration Expense Rate
      37.70% 216.360% -- 216.360% -- 375.720% 40.88% 157.120%
      Financial Health Ratios
      Long-Term Debt to Equity Ratio
      -- -- -- -- -- 192.807% -- --
      Total Assets to Common Equity
      -- -- -- -- -- 1332.124% -- --
      Debt to Asset Ratio
      -- -- -- -- -- 334.818% -- --
      Current Ratio
      333.77% 0.8127 -- 0.8127 -- 1.1256 -64.62% 0.1874
      Quick Ratio
      387.68% 0.7215 -- 0.7215 -- 0.9494 -68.82% 0.1479
      GrowthRatios
      Growth Ratios
      Revenue CAGR（3Y）
      -- 3.908% -- -- -- -- -- --
      Currency Unit
      GBPGBPGBPGBP

      FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

      Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

      The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

      Company Overview More
      CEO： Mr. Bryan Kobel
      Market： NASDAQ
      Listing Date： 02/11/2022
      Futu Hot List
      USHKCN
      TradeSearchNews
      SymbolLatest price%Chg

      Loading...

      Watchlist
      Back to the Top